A colon cancer-based study reported that formononetin inhibited cell proliferation and invasion via the inhibition of cyclin D1 and MMP-2/9 expression through p-STAT3, p-PI3K, and p-Akt inactivation [11]. Here, AKT1 is linked to malignant colon neoplasm.